United States · Biotechnology startup
United States · Edgemont Pharmaceuticals
Edgemont Pharmaceuticals focuses on the field of neuroscience and develops novel drug formulations and therapies to improve patient care.
Funding reportedLast round: Debt financing
Follow Edgemont Pharmaceuticals and see its new rounds in your feed.Start following
What company datasets say Edgemont Pharmaceuticals raised
Funding, as reported
Reported in all$9.8Min dollars
Rounds2
Last roundDebt financing
Last round dateMay 2015
Investors listed1
Founders and team
From the SEC filings it signed: 1 founder.
Douglas A. SaltelFounder of Company.Named on its 2010 Form Di
On the board, as filediBarbara A. DuncanRobert A. ZerbeTimothy A. McInerney
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Edgemont Pharmaceuticals in front of investors. Or tell us what we have wrong.